Skip to main content
. 2019 May 28;7:140. doi: 10.1186/s40425-019-0622-0

Fig. 7.

Fig. 7

Therapeutic targeting of tumor-associated macrophages in cancer. TAM are a promising target for the immunotherapy of cancer. Several approaches to reduce TAM or functionally modify TAM include blocking monocyte recruitment to the tumor, deletion through antigen-specific targeting, reprogramming of TAM to M1 macrophages and inhibiting the activation of TAM